Company

Combines bio-diagnostics commercialization with capital-markets expertise to lead YepBio's dual-track strategy in drug & diagnostics.

• QuratisCEOConcurrent
• Inventage LabDirectorFormer
• FlexSenseGlobal Sales HeadDiagnostics / Biomarker
• NEMO PartnersDirectorFormer
• Bank of New YorkAnalystFormer

The principal investigator who first identified PARIS. Translates 15+ years of ZNF746 research into clinical assets.

• SKKU School of MedicineProfessor, PharmacologyCurrent
• Johns Hopkins UniversityAdjunct Prof., NeurologyAdjunct

An operations veteranwith experience across both pharma R&D and regulatory authorities, architecting YepBio's R&D operations.

• YepBioR&D Center DirectorCurrent
• MediHelpLineHead of R&D
• Daewha · Hwain · SK ChemicalsPharma
• MFDS, KoreaMFDSRegulatory

Leads full-cycle licensing — sourcing, due diligence, term & contract negotiation, and Definitive Agreement execution.

• BiogenExecutive Director, BD & LicensingUSA
• AstraZenecaSenior DirectorUK

Harvard Medical School Professor of Neurology and former Director of NIH Udall Parkinson's Disease Research Center.

• Harvard Medical SchoolProfessor, Neurology
• Brigham and Women's HospitalDirector, Udall PD Center
• Link MedicineFounder
• Lysosomal TherapeuticsFormer CSO

Harvard Medical School, Chief of Movement Disorders. Leader in PGC-1α neuroprotection and multi-center PD clinical trials.

• Harvard Medical SchoolProfessor, Neurology
• Beth Israel Deaconess Medical CenterChief, Movement Disorders / NPF Center Director

Bridging pharmacology and neuroscience in academic leadership.

• SKKU School of MedicineProfessor, PharmacologyCurrent

Applying molecular neurobiology to clinical target discovery.

• Johns Hopkins UniversityAssoc. Prof., NeurologyCurrent
• KAISTAssociate ProfessorCurrent